RAIA DROGASIL SA -SPON ADR

TickerRADLY

Sector · IndustryHealthcarePharmaceutical Retailers

SecurityADR · US

CUSIP750723108

Watch

Share

Ask AIAsk AI about RADLY

1

Holders

$45,732

Total Value

100%

Consensus

Fund holdings as of Jun 30, 2026

RADLY (RAIA DROGASIL SA -SPON ADR) is held by 1 institutional investors as of Q2 2026. Top institutional shareholders: RhumbLine Advisers ($45,732).

No verdict yet — fewer than 2 funds hold RADLY.

Top Holders

FundsInsidersCongressActivists

Holdings (1)History

AllNewIncreasedHeldDecreasedExitedFirst report

Checking access…

Fund	Action	Shares	Value	Weight	Est. P&L	Conviction
RhumbLine Advisers	Increased	13,275(+113.9%)	$45,732	0.0%	-24.79%	22

Loading insider trades…

Loading Congress trades…

Loading activist filings…

RADLYRAIA DROGASIL SA -SPON ADR

1M3M6M1Y3Y5Y

Continue exploring

Smart money flow

Track where institutional capital is flowing

Discover new institutional entries

Fresh positions initiated this quarter

Check sector trends

Capital flows across GICS sectors

Other Healthcare stocks held by institutions

UNHUnitedHealth Group Incorporated

417 holders · $300.5B

LLYEli Lilly and Company

416 holders · $881.6B

TMOThermo Fisher Scientific Inc

401 holders · $151.5B

JNJJohnson & Johnson

398 holders · $415.6B

DHRDanaher Corporation

395 holders · $98.9B

ISRGIntuitive Surgical, Inc.

394 holders · $111.8B

MRKMerck & Company, Inc.

391 holders · $230.3B

ABBVAbbVie Inc.

386 holders · $303.9B

BSXBoston Scientific Corporation

386 holders · $52.4B

ABTAbbott Laboratories

383 holders · $114.2B

Questions investors ask about RADLY

Who owns RADLY?

1 institutional investor held RADLY on June 30, 2026, led by RhumbLine Advisers ($45,732).

How many hedge funds hold RADLY?

1 institutional investor reported RADLY in their 13F filings for the quarter ended June 30, 2026, $45,732 in all.

High Conviction Moves-Smart Money Convergence-Fund Consensus-Double-Down Detection

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer